Discussion Topic: Arrhythmic Prognosis According to Left Ventricular Systolic Dysfunction Severity in Cardiac Sarcoidosis
William H. Sauer, MD, FHRS, CCDS, Brigham and Women’s Hospital is joined by Edoardo Bressi, MD Queen Elizabeth Hospital – University Hospitals Birmingham, and Jordana Kron, MD Virginia Commonwealth University to discuss the current guidelines that present varying classes of recommendations for implantable cardioverter-defibrillator (ICD) utilization in patients with cardiac sarcoidosis (CS) and left ventricular ejection fraction (LVEF) <50%. This podcast episode explores a manuscript describing outcomes in these patients.
Host: William H. Sauer, MD, FHRS, CCDS
Guests: Jordana Kron, MD and Edoardo Bressi, MD
Speaker and Article Information: Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
Podcasts
The Lead Episode 125: A Discussion of Permanent Left Bundle Branch Area DF-4 Defibrillator Lead Implantation Feasibility, Procedural Caveats, Safety, and Follow-Up, LIVE at HRX
November 6, 2025
Podcasts
The Lead Episode 124: A Discussion of Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs to Treat Atrial Fibrillation: PRAGUE 25 Trial, LIVE at HRX
October 30, 2025
Podcasts
The Lead Episode 123: A Discussion of Re-Ablation of Atrial Fibrillation Targeting Electrogram Dispersion – The RESTART Trial LIVE at HRX
October 16, 2025